Jun 9, 20203 minNew consortium EUbOPEN will provide tools to unlock disease biology66 million euros to generate open-access chemical tools Frankfurt and Ingelheim, Germany – 08 June 2020 – Almost twenty years after...
Jun 2, 20202 minTwist Bioscience to join Proteona to protect immunocompromised patients from COVID-19 infection.Singapore, June 1st 2020 - Proteona today announced that Twist Bioscience (Nasdaq: TWST) will join the international alliance led by...
May 14, 20202 minUnderstanding the role of our genes in SARS-CoV-2 infectionsEMBL scientists will contribute to the new German COVID-19 OMICS Initiative to study the biological mechanisms contributing to ...
May 12, 20202 minProteona’s ESCAPE™ platform selected for SARS-CoV-2 vaccine characterizationSingapore, May 12th 2020 - Proteona announced today that it is beginning a partnership with Professor Nikolai Petrovsky from Flinders...
Mar 23, 20204 minOne more step towards true precision medicineProteona, Synovo, and NMI announced collaboration on a single cell multi-omics profiling platform for patient-derived micro-tumors...
Mar 12, 20202 min€2.45 m to investigate leukaemia causes and therapiesThe Heidelberg-based LeukoSyStem consortium investigates leukaemia stem cells in acute myeloid leukaemia. The German Federal Ministry of...
Feb 20, 20201 minArtificial pericardial tissue from the 3D printerTogether with its project partners, the NMI can already report initial successes in the PolyKARD project, specifically the synthesis and...
Jan 14, 20201 minBioMed X starts new schizophrenia research program with Boehringer IngelheimHeidelberg, Germany, January 13th, 2020 – BioMed X announced today the start of a new joint research group in collaboration with...
Jan 10, 20202 minBausch Health licenses Novaliq’s NOV03 investigational treatment for dry eye disease Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and Bausch + Lomb, its leading global eye health business, and Novaliq...
Jan 10, 20201 minBioMed X starts new research program in autoimmune diseases with MerckHeidelberg, Germany, January 9th, 2020 – BioMed X announced today the start of a new joint research group in collaboration with Merck....